Search Results

Search

Ethics Talk: Could Trusting Science Mean Not Trusting Some FDA Decisions?

Submitted by Audiey.Kao@ama… on

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Caleb Alexander about the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.

Click here to read the transcript.

G. Caleb Alexander, MD, MS is professor of epidemiology and medicine at Johns Hopkins Bloomberg School of Public Health.

Video

Recorded on June 22, 2021

 

Neurology Patient Care

Audio

 

Conflict of Interest Disclosure

Dr Alexander is past chair and current member of FDA's Peripheral and Central Nervous System Drugs Advisory Committee. He is a co-founding principal and equity holder in Monument Analytics, a health care consultancy whose clients include the life sciences industry as well as plaintiffs in opioid litigation. He was also a member of OptumRx's National Pharmacy and Therapeutics Committee.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Visibility and Measurability in Health Care Off

Ethics Talk: Virtue Ethics, Moral Authority, and COVID-19

Submitted by gale.saulsberr… on

In this special video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talked with Dr Edmund Pellegrino (1920-2013) about personal virtues in shaping ethical behavior and moral authority in promoting the common good.

Click here to read the transcript.

Edmund Pellegrino, MD was professor emeritus of medicine and medical ethics at Georgetown University.

Video

 

Professionalism

Audio

 

Conflict of Interest Disclosure
Interviewee is assumed to have no conflicts of interest.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image videocast2-2007 Issue Humor in Health Care CME Off
History of Medicine
Sep 2018

Why Does the Shift from “Personalized Medicine” to “Precision Health” and “Wellness Genomics” Matter?

Eric T. Juengst, PhD and Michelle L. McGowan, PhD
Transitions in relabeling personalized medicine as precision medicine, precision health, or wellness genomics reflect shifting the locus of responsibility for health from individuals to clinicians and in shifting focus from genetic risk to genetic enhancement.
AMA J Ethics. 2018; 20(9):E881-890. doi: 10.1001/amajethics.2018.881.
History of Medicine
May 2019

Will We Code for Default ECMO?

Daniel J. Brauner, MD and Christopher J. Zimmermann, MD
CPR has become default treatment for all patients in cardiac arrest. The history of how this happened demonstrates the power of CPT coding.
AMA J Ethics. 2019; 21(5):E443-449. doi: 10.1001/amajethics.2019.443.
Case and Commentary
Oct 2019

How Should We Determine the Value of CAR T-Cell Therapy?

Sara Silbert, MD, Gregory A. Yanik, MD, and Andrew G. Shuman, MD
“Living” drugs target specific B-cell malignancy tumor antigens, but cost hundreds of thousands of dollars. Value analysis can help determine whether to offer these customized drugs.
AMA J Ethics. 2019; 21(10):E844-851. doi: 10.1001/amajethics.2019.844.
Viewpoint
Oct 2019

What Clinical Ethics Can Learn From Decision Science

Michele C. Gornick, PhD, MA and Brian J. Zikmund-Fisher, PhD, MA
How information is provided can change a choice. Decision science helps reveal affective forecasting errors and can generate choices congruent with patients’ and families’ values.
AMA J Ethics. 2019; 21(10):E906-912. doi: 10.1001/amajethics.2019.906.
Viewpoint
Oct 2019

How Moral Case Deliberation Supports Good Clinical Decision Making

Giulia Inguaggiato, MPhil, Suzanne Metselaar, PhD, Bert Molewijk, PhD, and Guy Widdershoven, PhD
Clarifying both patients’ and professionals’ values fosters good clinical decision making, particularly in situations of uncertainty.
AMA J Ethics. 2019; 21(10):E913-919. doi: 10.1001/amajethics.2019.913.
podcast-1910
Podcast
Oct 2019

Ethics Talk: How Can Decision Science Help Navigate Complex Health Decisions?

Decision making in health care demands that we balance multiple considerations, like quality of life, statistics, and how different options could affect others. Dr Brian Zikmund-Fisher shares his own experience as a patient and explains how decision science can help us navigate ethically complex health decisions.